Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2020
Expanded Low Allele Frequency <i>RAS</i> and <i>BRAF</i> V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 TrialJonathan M Loree, Anthony Dowers, Dongsheng Tu, et al.
Journal of Clinical Medicine|September 25, 2019
Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour CareBraden Woodhouse, Sharon Pattison, Eva Segelov, et al.
The New England Journal of Medicine|November 16, 2007
Cetuximab for the treatment of colorectal cancerDerek J Jonker, Chris J O'Callaghan, Christos S Karapetis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical TrialsJoao Paulo Solar Vasconcelos, Nan Chen, Emma Titmuss, et al.
Investigational New Drugs|November 15, 2011
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combinationMichael Millward, Timothy Price, Amanda Townsend, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 21, 2014
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancerEric Van Cutsem, Yung-Jue Bang, Feng Feng-Yi, et al.
Current Problems in Cancer|August 23, 2020
Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancerThiru Prasanna, Rachel Wong, Timothy Price, et al.
European Journal of Clinical Pharmacology|September 4, 2021
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolitesZheng Liu, Jennifer H Martin, Winston Liauw, et al.
Pageof 13